Abstract
A group of 343 patients with bladder carcinomas was uniformly staged, both clinico-radiologically and pathologically. In accordance with pathological staging, they were treated from 1983 to 1990 and follow-up was closed on January 1992. No systemic chemotherapy regime was used. The present study was designed to assess the value of classical morphological parameters (tumour extension, histological subtype, grade and growth pattern) in the prediction of prognosis, and also to evaluate the adequacy of the current TNM classification (4th edition, 1987) of bladder cancer. The initial tumour stage appears the most useful criterion in the prediction of prognosis. Nevertheless, survival analysis confirms the necessity to modify the present TNM classification for routine clinical practice. In fact, stage III proves to be heterogeneous, and the difference in survival between categories pT3a and pT3b is even more statistically significant (logrankP<0.01) than the difference between pT2 and pT3 as a whole (log-rankP<0.02). Consequently, invasion of the muscular layer should be reclassified into a common stage II, equivalent to the B category in the ABCD system. Moreover, stage IV is also heterogeneous in terms of survival. Despite the overall life-expectancy being rather poor for a patient with bladder carcinoma, three subsets with different prognosis (log-rankP<0.001) can be identified: pT4N0M0; pTxN1-3M0; pTxNyM1, wherex andy represent any number. Therefore, we believe that various subgroups should be distinguished in a future edition of the TNM classification. Current treatment modalities, involving the role of systemic chemotherapy and aimed at bladder preservation, make such innovations even more convenient for a new edition of the TNM classification of bladder cancer. Apart from tumour staging, several microscopic morphological parameters are valuable in distinguishing patients with different prognosis. Pure transitional-cell histology, papillar growth, and low grade, are favourable data. In fact, tumour grade, although somewhat subjective, is a factor of major prognostic importance. Pauwels' distinction of intermedium grade 2 into 2A and 2B is also helpful in the assessment of a population of “intermediate” prognosis. Similarly, with regard to superficial tumours, the division of infiltration levels of subepithelial connective tissue into “superficial” or “deep into the muscularis mucosae”, is also relevant, even after stratification by grade.
Article PDF
Avoid common mistakes on your manuscript.
Abbreviations
- TCC:
-
transitional-cell carcinoma
- TUR:
-
transurethral resection
- MM:
-
muscularis mucosae
References
Abel PB, Henderson D, Bennett MK, Hall RR, Williams G (1988) Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol 62:339–342
AJCC (American Joint Committee on Cancer) (1983) Beahrs OH, Myers MH (eds) Manual for staging of cancer, 2nd edn. Lippincott, Philadelphia
Algaba F (1991) Atlas de patología de los tumores urogenitales. Pulso Ediciones, Barcelona, pp. 85–185
Ayala AG, Ro JY (1989) Premalignant lesions of the urothelium and transitional cell tumors. In: Young RH (ed) Pathology of the urinary bladder. Churchill Livingstone, New York, p 65
Batata MA, Chu FCH, Hilaris BS (1981) Factors of prognostic and therapeutic significance in patients with bladder cancer. Int J Radiat Oncol Biol Phys 7:575–579
Barnes RW, Dick AD, Hadley HL, Johnston OL (1977) Survival following transurethral resection of bladder carcinoma. Cancer Res 37:2895–2897
Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 130:371–378
Blomjous ECM, Schipper NW, Baak JPA, Vos W, De Voogt HJ, Meijer CJLM (1989) The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 91:243–248
Carbin B, Ekman P, Gustafson H, Christensen NJ, Sandstedt B, Silfverswärd C (1991a) Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description. J Urol 145:968–971
Carbin B, Ekman P, Gustafson H, Christensen NJ, Silfverswärd C, Sandstedt B (1991b) Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II. Prognostic importance. J Urol 145:972–976
Catalona WJ (1991) Bladder cancer. In: Gillenwater JY, Graghack J, Howard S (Eds) Adult and pediatric urology, 2nd edn. Mosby-Year Book, St. Louis, p 1141
Chisholm GD (1988) TNM classification of urological tumours in 1988. Br J Urol 62:501
Chisholm GD, Hindmarsh JR, Howatson AG, Webb JN, Busuttil A, Hargreave TB, Newsam JE (1980) TNM 1978 in bladder cancers: use and abuse. Br J Urol 52:500–505
Cifuentes-Delatte L, Garcia de la Peña E, Vela Navarrete R (1982) Survival rates of patients with bladder tumours. An experience of 1744 cases (1950–1978). Br J Urol 54:267–274
Cifuentes-Delatte L, Garcia de la Peña E, Vela Navarrete R (1984) Further comments on 1744 bladder tumors. In: Küss R, Khoury S, Denis LJ, Murphy GP, Karr JP (eds) Bladder cancer, part A: pathology, diagnosis and surgery. Liss, New York, pp 301–305
Collan Y, Mäkinen J, Heikkinen A (1979) Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis. Eur Urol 5:311–318
Colpaert C, Goovaerts G, Buyssens N (1987) Factors influencing the subjective grading of bladder cancer. Virchows Arch [A] 411:479–484
Cotran RS, Kumar V, Robbins SL (1989) The lower urinary tract. In: Pathologic Basis of Disease, 4th ed. Saunders, Philadelphia, pp 1083–1097
Denis LJ (1992) Clinical staging: its importance in therapeutic decisions and clinical trials. Hematol Oncol Clin North Am 6:41–58
Fradet Y (1990) Biological markers of prognosis in invasive bladder cancer. Semin Oncol 17:533–543
Friedell GH (1987) Urinary bladder cancer. Selecting initial therapy. Cancer 60:496–501
Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, Muldoon TM, Lonni YW, Rowe JH, Cooper JF, Nussbaum H, Chan P, Rao A, Starr A (1978) The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J Urol 119:488–492
Greven KM, Solin LJ, Hanks GE (1990) Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65:908–912
Hall RR, Prout GR (1990) Staging of bladder cancer: is the tumor, node, metastasis adequate? Semin Oncol 17:517–523
Hall RR, Beynon LL, Horwich A, Kaye S, Tolley D (1988) Urology and the TNM classification. Lancet II:1145–1154
Helpap B (1992) Grading and prognostic significance of urologic carcinomas. Urol Int 48:245–257
Helpap B, Schwabe HW, Adolphs HD (1985) Proliferative pattern of urothelial bladder cancer and urothelial atypias. J Cancer Res Clin Oncol 109:46–54
Hendry WF, Rawson NSB, Turley L, Dunlop A, Whitfield HN (1990) Computerisation of urothelial carcinoma records: 16 years' experience with the TNM system. Br J Urol 65:583–588
Heney NM, Proppe K, Prout GR Jr, Griffin PP, Shipley WU (1983) Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 130:895–897
Herr HW (1987) Conservative management of muscle infiltrating bladder cancer: prospective experience. J Urol 138:1162–1163
Jacobi GH, Engelmann U, Hohenfellner R (1985) Classification of bladder tumours. In: Zingg EJ, Wallace DMA (eds) Bladder cancer. Springer, Berlin Heidelberg New York, pp 117–139
Jacobsen AB, Pettersen EO, Amellem O, Berber A, Ous S, Fossa SD (1992) The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 147:34–37
Jewett HJ (1952) Carcinoma of the bladder: influence of the depth of infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 67:672–680
Jewett HJ (1978) Comments on staging of invasive bladder cancer. Two B's or not two B's: that is the question. J Urol 119:39–42
Jewett HJ, Lewis EL (1948) Infiltrating carcinoma of the bladder: curability by total cystectomy, J Urol 60:107
Jewett HJ, Strong GH (1946) Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol 55:366
Jewett HJ, King LR, Shelley WJ (1964) A study of 365 cases of infiltrating bladder cancer: relation of certain pathological characteristics to prognosis after extirpation. J Urol 92:668–678
Jordan AM, Weingarten J, Murphy WM (1987) Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 60:2766–2774
Kakizoe T, Matumoto K, Nishio Y (1985) Significance of carcinoma in situ and dysplasia in association with bladder cancer. J Urol 133:395–398
Kakizoe K, Tobisu K, Takai K (1988) Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 48:2293–2303
Kaplan EL, Meier P (1958) Non-parametric estimations from incomplete observations. J Am Stat Assoc 53:457–481
Kaufman DS, Shipley WU, Althausen AF (1992) Radiotherapy and chemotherapy in invasive bladder cancer with potential bladder sparing. Hematol Oncol Clin North Am 6:179–194
Keep JC, Piehl M, Miller A, Oyasu R (1989) Invasive carcinoma of the urinary bladder. Evaluation of tunica muscularis mucosae involvement. Am J Clin Pathol 91:575–579
Kern WH (1984) The grade and pathologic stage of bladder cancer. 53:1185–1189
Koss LG (1975) Tumours of the urinary bladder. Atlas of tumor pathology, series 2, fascicle 11. Armed Forces Institute of Pathology, Washington DC
Lipponen PK, Collan Y, Eskelinen MJ, Personen E, Sotarauta M, Nordling S (1990a) Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer. Br J Urol 65:589–597
Lipponen PK, Kosma VM, Collan Y, Kulju T, Kosunen O, Eskelinen M (1990b) Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol 17:333–337
Lipponen PK, Eskelinen MJ, Kiviranta J, Pesonen E (1991) Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. J Urol 146:1535–1540
Maffezzini M, Torelli T, Villa E, Corrada P, Bolognesi A, Leidi GL, Rigatti P, Campo B (1991) Systemic preoperative chemotherapy with cisplatin, methotrexate and vinblastine for locally advanced bladder cancer: local tumor response and early followup results. J Urol 145:741–743
Malmström PU, Busch C, Norlen BJ (1987) Recurrence, progression and survival in bladder cancer. A retrospective analysis of 323 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 21:185–195
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 22:719–748
Marshall VF (1952) The relation of the pre-operative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68:714–723
Melamed MR, Vousta NG, Grabstaldt H (1964) Natural history and clinical behaviour of carcinoma in situ of the human urinary bladder. Cancer 17:1533–1545
Mostofi FK (1954) Potentialities of bladder epithelium. J Urol 71:705
Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumors. International classification of tumors, no. 10. World Health Organisation, Geneva
Murphy WM (1983) Current topics in the pathology of bladder cancer. Pathol Annu 18:1–25
Narayana AS, Loening SA, Slymen DJ (1983) Bladder cancer: factors affecting survival. J Urol 130:56–60
Ooms ECM, Anderson WAD, Alons CL, Boon ME, Veldhuizen RW (1983) Analysis of the preformance of pathologists in the grading of bladder tumors. Hum Pathol 14:140–143
Pagano F, Bassi P, Prayer Galetti T, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145:45–50
Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM (1988a) Grading in superficial bladder cancer. 1. Morphological criteria. Br J Urol 61:129–134
Pauwels RPE, Smeets AWGB, Schapers RFM, Geraedts JPM, Debruyne FMJ (1988b) Grading in superficial bladder cancer. 2. Cytogenetic classification. Br J Urol 61:135–139
Prout GR, Griffin PP, Daly JJ (1983) Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer 52:524–532
Pryor JP (1973) Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 45:586–592
Quilty PM, Duncan W (1986) Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12:858–886
Raghavan D (1988) Preemptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer. Br J Urol 61:1–8
Raghavan D, Wallace M (1990) Preemptive (neoadjuvant) chemotherapy: can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons? Semin Oncol 17:613–618
Reuter V (1990) Pathology of bladder cancer: assessment of prognostic variables and response to therapy. Semin Oncol 17:524–532
Ro JY, Ayala AG, El-Naggar A (1987) Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 11:668–673
Scher HI (1990) Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvant. Semin Oncol 17:555–565
Scher HI, Yagoda A, Herr H, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RD, Dershaw DD, Reuter V, Geller N, Hollander P, Vaughan ED, Whitmore WF, Fair W (1988) Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol 139:470–474
Schröder FH, Cooper EH, Debruyne FMJ, Denis L, Newling DWW, Pavone-Macaluso M, Smith PH, Sylvester R, and Members of the EORTC-GU Group (1988) TNM classification of genitourinary tumours 1987. Position of the EORTC Genitourinary Group. Br J Urol 62:502–510
Shipley WU, Rose MA, Perrone TL, Mannix CM, Heney NM, Prout GR Jr (1985) Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134:679–683
Shipley WU, Prout GR Jr, Kaufman D, Perrone TL (1987) Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60:514–520
Sjolin KE, Nyholm K, Trautner K (1976) Studies of transitional cell tumours of the bladder. Acta Pathol Microbiol Scand [A] 84:361–374
Skinner DG (1977) Current state of classification and staging of bladder cancer. Cancer Res 37:2838–2844
Skinner DG, Kaufman JJ (1978) Management of invasive and high grade bladder cancer. In: Skinner DG, DeKernion JB (eds) Genitourinary cancer. Saunders, Philadelphia, pp 269–283
Skinner DG, Lieskovsky G (1984) Contemporary cistectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 131:1069–1072
Skinner DG, Lieskovsky G (1988) Management of invasive and highgrade bladder cancer. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer. Saunders, Philadelphia, pp 295–312
Slack NH, Prout GR Jr (1980) The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol 123:644–652
Slack NH, Bross IDJ, Prout GR (1977) Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 9:393–405
Soto EA, Friedell GH, Tiltman AJ (1977) Bladder cancer as seen in giant histologic sections. Cancer 39:447–455
Torti FM, Lum BL (1984) The biology and treatment of superficial bladder cancer. J Clin Oncol 2:505
Torti FM, Lum BL, Aston D (1987) Superficial bladder cancer: the primary of grade in the development of invasive disease. J Clin Oncol 5:125–130
UICC (Union Internationale Contre le Cancer) (1974) TNM classification of malignant tumors. G. de Buren, Geneva
UICC (Union Internationale Contre le Cancer) (1978) Harmer MH (ed) TNM classification of malignant tumors, 3rd edn. International Union against Cancer, Geneva
UICC (Union Internationale Contre le Cancer) (1982) Spiessl B, Scheibe O, Wagner G (eds) TNM atlas: illustrated guide to the classification of malignant tumors. Springer, Berlin Heidelberg New York
UICC (Union Internationale Contre le Cancer) (1987) Hermanek P, Sobin LH (eds) Classification of malignant tumors, 4th edn. International Union against Cancer, Geneva
Van der Werf-Messing B, Menon RS, Hop WCJ (1983) Carcinoma of the urinary bladder T3NXM0 treated by the combination of radium implant and external irradiation: second report. Int J Radiat Oncol Biol Phys 9:177–180
Walther PJ (1992) The role of flow cytometry in the management of bladder cancer. Hematol Oncol Clin North Am 6:81–98
Webb JN (1985) The histopathology of bladder cancer. In: Zingg EJ, Wallace DMA (eds) Bladder cancer. Springer Berlin Heidelberg New York, pp 23–51
Younes M, Sussman J, True LD (1990) The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 66:543–548
Author information
Authors and Affiliations
Additional information
The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author
This work has been supported by an institutional grant from the Health Department of the Basque Government, and is also part of the doctoral thesis of one of the authors (J. C. Angulo)
Rights and permissions
About this article
Cite this article
Angulo, J.C., Lopez, J.I., Flores, N. et al. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification. J Cancer Res Clin Oncol 119, 578–593 (1993). https://doi.org/10.1007/BF01372721
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01372721